/
Other
Airway Obstruction
16
Pipeline Programs↗
2
Active Trials↗
9
Companies Involved↗
Airway obstruction is an emerging landscape with 16 programs across 9 companies. The most active players are AstraZeneca, Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical15
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
75%
Small molecule
12 of 16 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 16 classified programs, each share of the total. Modality classified for 100% of 16 pipeline programs.
Analysis
Trial Status
16
clinical trials
Completed10 · 63%
Unknown status4 · 25%
Not yet recruiting1 · 6%
Recruiting1 · 6%
Clinical Trials
Trial Activity
16 trials
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)